Advertisement

Topics

Latest "BioTech Capital Limited" News Stories

04:07 EST 17th November 2018 | BioPortfolio

Here are the most relevant search results for "BioTech Capital Limited" found in our extensive news archives from over 250 global news sources.

More Information about BioTech Capital Limited on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about BioTech Capital Limited for you to read. Along with our medical data and news we also list BioTech Capital Limited Clinical Trials, which are updated daily. BioPortfolio also has a large database of BioTech Capital Limited Companies for you to search.

Showing "BioTech Capital Limited" News Articles 1–25 of 10,000+

Saturday 17th November 2018

NextCure Closes $93 Million B Round Led by China Investors for IO Therapies

NextCure of Maryland closed a $93 million series B financing led by China investors Hillhouse Capital and Quan Capital. The financing will support NextCure's next-gen immunomedicines for cancer and other diseases, especially NC318, a first-in-class molecule aimed at S15. S15 is a novel immunomodulatory target associated with lung, ovarian and head and neck cancers. NextCure is also using its FIND-...


Friday 16th November 2018

Alphamab Oncology Completes Series-A Round Financing - Further Strengthening Its Global Innovative Biologics Platforms

SUZHOU, China, Nov. 17, 2018 /PRNewswire/ -- Alphamab Oncology announced the successful completion of series A financing round, with more than $100 million raised. A number of well-regarded institutional investors, including Advantech Capital, PAG, China Venture Capital Fund[1], OrbiMed, Heritage Provider Network and Janchor Partners, participated in the financing. Alphamab Oncology plans to use...

Kala Pharmaceuticals Inc KALA Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummaryKala Pharmaceuticals Inc Kala Pharmaceuticals is a clinical stage pharmaceutical company that offers nanoparticlebased treatments for ocular diseases affecting both front and back of the eye. The company's lead program MPP nanosuspension of an ophthalmic corticosteroid is under phase III clinical development for the treatment of postsurgical inflammation, meibomian gland disease, ocular inf...


Shield Therapeutics Completes £12M Fundraising

Newcastle-based Shield Therapeutics has completed its £12m fundraising. The pharmaceutical firm yesterday revealed plans to raise the money through a co-ordinated exercise of existing warrants at an exercise price of 150p per share to raise approximately £10.3m, a placing of new ordinary shares at 150p per share to raise about £1.5m and a subscription of new ordinary shares at 1...

Ontario Bioscience Innovation Organization Announces a Call for Applications for the 2019 Capital Access Advisory Program (CAAP®)

The Ontario Bioscience Innovation Organization (OBIO®), the leading advocate for Ontario’s health science industry, is pleased to announce a call for applications for the 2019 OBIO Capital Access Advisory Program (CAAP®). OBIO CAAP is a unique, industry-led initiative that provides selected high-potential Ontario health science companies with ...

Through ongoing R&D and capital investments, we continue our quest to improving healthcare --and have an impact on-- countless people’s lives. Learn more about why & how we’re #InventingForLife: https://bit.ly/2qHA6ow pic.twitter.com/QFSxKdWdtF

Through ongoing R&D and capital investments, we continue our quest to improving healthcare --and have an impact on-- countless people’s lives. Learn more about why & how we’re #InventingForLife: https://bit.ly/2qHA6ow  pic.twitter.com/QFSxKdWdtF

AbbVie Enters Industry Collaboration to Fight Alzheimer’s and Parkinson’s Disease

The UK biotech Mission Therapeutics has teamed up with AbbVie to develop new drugs to treat the neurodegenerative conditions Alzheimer’s disease and Parkinson’s disease. The new collaboration aims to fund the preclinical development of drugs that inhibit proteins called deubiquitinating ... The post AbbVie Enters Industry Collaboration to Fight Alzheimer’s and Parkinson’s Disease appea...

Cisco Systems leidet unter negativen Einflüssen!

Chicago (www.aktiencheck.de) - Cisco Systems-Aktienanalyse von Analyst James Kisner von Loop Capital: Analyst James Kisner von Loop Capital empfiehlt die Aktien des Anbieters von Networking-Lösunge...

MorphoSys and I-Mab Sign Strategic Partnering Agreement for MorphoSys’s Novel Immuno-Oncology Agent MOR210

MorphoSys AG (FSE: MOR; Prime Standard Segment, MDAX & TecDAX; NASDAQ: MOR) and I-Mab Biopharma (“I-Mab”), a biotech company focusing exclusively on innovative biologics in immuno-oncology and autoimmune diseases, jointly announced today that they have entered into an exclusive strategic collaboration and regional licensing agreement for MOR210. MOR210 is MorphoSys’s propriet...

Concept Life Sciences extends GLP to support regulatory studies

MHRA confirms extension at Dundee and Bradford sites. Accreditation ensures quality and integrity of non-clinical laboratory studies to support pharmaceutical and biotech industries

Landmark Health Names Anna Gill as Chief Human Resources Officer

Landmark Health (“Landmark”), an industry leader of in-home, risk-based medical care, announced today that Anna Gill has been named its Chief Human Resources Officer (“CHRO”), effective November 5, 2018. “Our greatest asset is our people,” stated Nick Loporcaro, CEO of Landmark. “We are thrilled Anna has joined Landmark to help further ...

Guangzhou Wondfo Biotech Co Ltd 300482 Medical Equipment Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummaryGuangzhou Wondfo Biotech Co Ltd Wondfo is a biological company that develops, manufactures and supplies rapid diagnostic reagents and related equipment. Its products include rapid quantitative test, immunofluorescent test system, glucose monitoring system, and raw materials. Wondfo also offers fertility tests, drug of abuse tests, POCT detection equipment, cardiovascular products, diabetes ...

Alliance Growers Commences Site Work at Cannabis Biotech Complex

Vancouver, British Columbia--(Newsfile Corp. - November 16, 2018) - Alliance Growers Corp. (CSE: ACG) (FWB: 1LA) (WKN: A2DFYX) ("Alliance" or "the Company") is pleased to announce that its partner ...

$ARNA PT raised to $70 from $65 at RBC Capital

$ARNA PT raised to $70 from $65 at RBC Capital

This is the big issue weighing down biotech stock prices: As new therapies arrive, pressure builds on the health care system to figure out how to pay for them https://www.statnews.com/2018/11/15/value-based-pricing-new-therapies/ … via @statnews

This is the big issue weighing down biotech stock prices: As new therapies arrive, pressure builds on the health care system to figure out how to pay for them https://www.statnews.com/2018/11/15/value-based-pricing-new-therapies/ … via @statnews

Astellas Pharma Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 12102018] Prices from USD $175

Astellas Pharma Inc. Strategy, SWOT and Corporate Finance ReportSummaryAstellas Pharma Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.Key HighlightsAstellas Pharma Inc. Astellas ...

Sunrise Senior Living LLC Strategy, SWOT and Corporate Finance Report [Report Updated: 12102018] Prices from USD $175

Sunrise Senior Living LLC Strategy, SWOT and Corporate Finance ReportSummarySunrise Senior Living LLC Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.Key HighlightsSunrise Senior Livin...

Civitas Solutions, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 12102018] Prices from USD $175

Civitas Solutions, Inc. Strategy, SWOT and Corporate Finance ReportSummaryCivitas Solutions, Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.Key HighlightsCivitas Solutions, Inc. ...

Regis Healthcare Ltd Strategy, SWOT and Corporate Finance Report [Report Updated: 12102018] Prices from USD $175

Regis Healthcare Ltd Strategy, SWOT and Corporate Finance ReportSummaryRegis Healthcare Ltd Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.Key HighlightsRegis Healthcare Ltd Regis is ...

The F. Dohmen Co. Strategy, SWOT and Corporate Finance Report [Report Updated: 05102018] Prices from USD $175

The F. Dohmen Co. Strategy, SWOT and Corporate Finance ReportSummaryThe F. Dohmen Co. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.Key HighlightsThe F. Dohmen Co. Dohmen or 'the com...

Catalent Inc Strategy, SWOT and Corporate Finance Report [Report Updated: 05102018] Prices from USD $175

Catalent Inc Strategy, SWOT and Corporate Finance ReportSummaryCatalent Inc Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.Key HighlightsCatalent, Inc. Catalent or the company' is a p...

Ansell Limited Strategy, SWOT and Corporate Finance Report [Report Updated: 03102018] Prices from USD $175

Ansell Limited Strategy, SWOT and Corporate Finance ReportSummaryAnsell Limited Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.Key HighlightsAnsell Limited Ansell or the company' is a...

Hoya Corporation Strategy, SWOT and Corporate Finance Report [Report Updated: 01102018] Prices from USD $175

Hoya Corporation Strategy, SWOT and Corporate Finance ReportSummaryHoya Corporation Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.Key HighlightsHoya Corporation Hoya or 'the company'...

CSL Limited Strategy, SWOT and Corporate Finance Report [Report Updated: 01102018] Prices from USD $175

CSL Limited Strategy, SWOT and Corporate Finance ReportSummaryCSL Limited Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.Key HighlightsCSL Limited CSL or the group' is a leading globa...

Hypera SA Strategy, SWOT and Corporate Finance Report [Report Updated: 15102018] Prices from USD $175

Hypera SA Strategy, SWOT and Corporate Finance ReportSummaryHypera SA Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.Key HighlightsHypera SA Hypera formerly, Hypermarcas SA, is a manu...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks